Infusystem Holdings Inc (INFU) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Infusystem Holdings Inc  (NYSEAMER: INFU)

Select the Financial Report: Select the Period:


Description of Infusystem Holdings Inc's Business Segments


Infusystem Holdings Inc is a leading entity in the healthcare sector, primarily focusing on providing infusion pumps and related products and services aimed at improving patient outcomes while actively working to reduce healthcare costs. The company operates through two crucial business segments: Specialty Infusion and Oncology, and Pain Management. Below is an in-depth exploration of the segments, products, and services Infusystem offers.

Specialty Infusion and Oncology

This segment is dedicated to supplying hospitals, clinics, and other healthcare providers with a broad array of specialized infusion products and services essential for managing patient care in oncology and other specialty fields.

1. Infusion Pumps:
- Ambulatory Infusion Pumps: These portable devices allow patients to receive medication or nutritional therapy while maintaining an active lifestyle. They are especially suited for long-term therapies that require continuous administration of fluids.
- Syringe Infusion Pumps: These compact pumps accurately deliver precise doses of medications over a controlled time period, typically ideal for infusions that require continuous monitoring.
- Large Volume Infusion Pumps: Designed for outpatient or inpatient settings, these pumps handle the administration of larger volumes of fluids and medications, ensuring timely delivery across various therapies.

2. Medication Management Software:
- Infusystem offers sophisticated software solutions that assist healthcare providers in managing infusion therapies effectively. The software enables tracking of medication inventory, patient histories, and infusion schedules, thereby enhancing the safety and efficiency of patient treatment. This technology supports clinicians in making informed decisions and optimizing patient outcomes.

3. Infusion Therapy Services:
- The company provides highly trained infusion nurses who administer therapy directly to patients in various settings, including outpatient clinics and at home. This service is particularly valuable for patients requiring ongoing infusion therapy, as it ensures clinical oversight throughout the treatment process.

4. Peripheral IV Catheter Management:
- Infusystem supplies peripheral IV catheters and ancillary products designed to facilitate effective management of peripheral intravenous access. An emphasis is placed on minimizing associated risks, such as infections or infiltration, ensuring that patients receive safe and reliable care.

Pain Management

This segment focuses on delivering specialized solutions aimed at pain relief for patients, ranging from acute conditions to chronic pain scenarios.

1. Pain Management Pumps:
- Patient-Controlled Analgesia (PCA) Pumps: These devices empower patients to manage their own pain relief by allowing them to administer specified doses of analgesics within prescribed limits. This personalized approach can lead to higher patient satisfaction and improved pain control.
- Epidural Pumps: Specifically used for administering medication directly to the epidural space, these pumps are essential in managing pain during and after surgeries, as well as in chronic pain conditions.

2. Pain Management Services:
- Infusystem provides skilled pain management nurses who are adept at administering a variety of pain management therapies. This service ensures that patients have continuous access to professional care, improving the safety and efficacy of the treatment they receive.

3. Durable Medical Equipment (DME):
- A comprehensive range of DME products, including braces, splints, and orthotic supports, is offered to enhance pain management efforts. These devices aid in improving patient mobility, stabilizing affected areas, and minimizing discomfort, which can significantly enhance recovery and quality of life.

Conclusion

Infusystem Holdings Inc takes a holistic approach to healthcare by providing a wide spectrum of products and services that cater to both infusion therapy and pain management needs. Their offerings extend across advanced technology solutions, experienced clinical support, and essential medical equipment, all aimed at enhancing the quality of patient care and operational efficiency within the healthcare sector. Through its specialized services and innovative products, Infusystem continues to make significant strides in improving patient outcomes and satisfaction within the healthcare landscape.


Composition of Infusystem Holdings Inc Revenues by Segments

 
Patient Services    126.97 % of total Revenue
Device Solutions    73.6 % of total Revenue
Patient Services And Device Solutions    149.63 % of total Revenue
Corporate and Eliminations    -9.37 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Patient Services 46.89 126.97 %
Device Solutions 27.18 73.6 %
Patient Services And Device Solutions 55.26 149.63 %
Corporate and Eliminations -3.46 -9.37 %
Total 36.93 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Patient Services 117.92 % 112.14 %
Device Solutions 67.23 % 105.6 %
Patient Services And Device Solutions - -
Corporate and Eliminations - -
Total 2.59 % 9.65 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 3.23 8.75 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total 24.32 % 217.7 %




Annual Report on Infusystem Holdings Inc Divisions, Sales by Country

 
Patient Services   Patient Services Segment contribution to total sales 60.33 % of total Revenue
Device Solutions   Device Solutions Segment contribution to total sales 44.69 % of total Revenue
Patient Services and Device Solutions   Patient Services and Device Solutions Segment contribution to total sales 78.84 % of total Revenue
Device Solutions Transferred over Time   Device Solutions Transferred over Time Segment contribution to total sales 24.33 % of total Revenue
Third-Party Payer Rentals Patient Services Transferred at Point in Time   Third-Party Payer Rentals Patient Services Transferred at Point in Time Segment contribution to total sales 12.37 % of total Revenue
Third-Party Payer Rentals Patient Services Transferred over Time   Third-Party Payer Rentals Patient Services Transferred over Time Segment contribution to total sales 34.92 % of total Revenue
Services Device Solutions Transferred at Point in Time   Services Device Solutions Transferred at Point in Time Segment contribution to total sales 8.25 % of total Revenue
Services Device Solutions Transferred over Time   Services Device Solutions Transferred over Time Segment contribution to total sales 4.04 % of total Revenue
Corporate Eliminations   Corporate Eliminations Segment contribution to total sales -5.01 % of total Revenue
Direct Payer Rentals Patient Services Transferred over Time   Direct Payer Rentals Patient Services Transferred over Time Segment contribution to total sales 5.41 % of total Revenue
Products Patient Services Transferred at Point in Time   Products Patient Services Transferred at Point in Time Segment contribution to total sales 1.81 % of total Revenue
Products Device Solutions Transferred at Point in Time   Products Device Solutions Transferred at Point in Time Segment contribution to total sales 12.04 % of total Revenue


Twelve months ended 2025
INFU s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Patient Services 86.53 60.33 %
Device Solutions 64.10 44.69 %
Total 143.44 100 %
Patient Services and Device Solutions 113.08 78.84 %
Device Solutions Transferred over Time 34.89 24.33 %
Third-Party Payer Rentals Patient Services Transferred at Point in Time 17.75 12.37 %
Third-Party Payer Rentals Patient Services Transferred over Time 50.09 34.92 %
Services Device Solutions Transferred at Point in Time 11.83 8.25 %
Services Device Solutions Transferred over Time 5.79 4.04 %
Corporate Eliminations -7.19 -5.01 %
Direct Payer Rentals Patient Services Transferred over Time 7.76 5.41 %
Products Patient Services Transferred at Point in Time 2.59 1.81 %
Products Device Solutions Transferred at Point in Time 17.27 12.04 %


Twelve months ended 2025
INFU s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Patient Services 55.37 63.99 %
Device Solutions 24.92 38.88 %
Total 6.63 4.62 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Patient Services 7.66 % 4.79 %
Device Solutions 3.82 % 41.92 %
Total 6.36 % 182.6 %
Patient Services and Device Solutions 6.38 % -
Device Solutions Transferred over Time 4.17 % -
Third-Party Payer Rentals Patient Services Transferred at Point in Time 18.15 % -
Third-Party Payer Rentals Patient Services Transferred over Time 5.69 % -
Services Device Solutions Transferred at Point in Time 33.5 % -
Services Device Solutions Transferred over Time -28.36 % -
Corporate Eliminations - -
Direct Payer Rentals Patient Services Transferred over Time 0.94 % -
Products Patient Services Transferred at Point in Time -4.25 % -
Products Device Solutions Transferred at Point in Time 4.36 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.